Ag-In-Se Nanoparticles for Near-Infrared Bioimaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bioimaging techniques face challenges in achieving high-resolution biological information due to the lack of strong light emission in the near-infrared region, particularly within the 'biological window' of 700 to 1400 nm, where the emission spectrum is not steep and sharp enough, leading to inferior resolution and difficulty in obtaining desired biological information.

Innovation Solution

The development of Ag—In—Se based compound semiconductor nanoparticles with a chalcopyrite crystal structure, where the peak wavelength of emission intensity is controlled within 700 to 1400 nm and the half-value width is kept at 100 nm or less, utilizing a method that involves preparing Ag—In precursor and Se precursor solutions, heating them to improve crystallinity and suppress defect generation, thereby achieving band-edge luminescence with reduced energy loss.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If conventional light emitters are used in bioimaging, then the imaging process is simple and safe, but the light emission intensity is insufficient and the resolution is inferior

Engineering Contradiction:
Improvelight emission intensityVSAvoidbiological information resolution
Core Design Contradiction:
Illumination intensityVSMeasurement precision

Solution Approach 1:

The patent changes the material composition parameters of the light emitter by using Ag-In-Se compound semiconductors with specific atomic ratios (Ag:In:Se = 1:1:2 or Ag:In:Se = 1:2:4), which fundamentally alters the optical properties to achieve strong near-infrared emission with narrow half-value width, thereby simultaneously improving emission intensity and measurement precision

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite material design by combining Ag, In, and Se elements in specific ratios to create Ag-In-Se compound semiconductor nanoparticles with chalcopyrite crystal structure, which exhibits superior optical properties including strong near-infrared emission and narrow emission spectrum, resolving the contradiction between emission intensity and resolution

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If the emission spectrum is not steep and sharp, then the light emitter can be easily manufactured, but the biological information resolution is inferior

Engineering Contradiction:
Improvebiological information resolutionVSAvoidemission spectrum sharpness
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The patent achieves sharp emission spectrum through precise control of material composition parameters (Ag:In:Se ratios) and particle size parameters (5-50 nm), which quantum confinement effects to produce narrow half-value width emission spectra, thereby achieving high biological information resolution without compromising manufacturability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality principle by optimizing the crystal structure at the nanoscale level, creating chalcopyrite structure with specific local atomic arrangements that produce steep and sharp emission spectra, enabling high resolution while maintaining ease of manufacture through solution-based synthesis

Inventive Principle:
Principle #3Local quality

3Illumination intensity

If Ag-In-Se compound semiconductor nanoparticles are used, then strong near-infrared luminescence is achieved, but the manufacturing process becomes more complex

Engineering Contradiction:
Improvenear-infrared luminescence intensityVSAvoidmanufacturing process complexity
Core Design Contradiction:
Illumination intensityVSDevice complexity

Solution Approach 1:

The patent simplifies manufacturing by optimizing the synthesis parameters including reaction temperature (200-300°C), reaction time (0.5-2 hours), and precursor ratios, which enables controlled formation of Ag-In-Se nanoparticles with desired optical properties through straightforward hydrothermal or solvothermal processes, maintaining ease of manufacture while achieving strong near-infrared luminescence

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes the relationship between particle size and emission wavelength (quantum confinement effect) to tune the near-infrared emission characteristics, allowing control of emission peak position and intensity through size control during synthesis, thereby achieving strong luminescence with relatively simple manufacturing by adjusting size parameters

Inventive Principle:
Principle #32Color changes

4Manufacturing precision

If the half-value width is not controlled to 100 nm or less, then the manufacturing process is simpler, but the emission spectrum is not steep and sharp enough

Engineering Contradiction:
Improveemission spectrum controlVSAvoidproduction simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent achieves narrow half-value width (≤100 nm) by precise control of composition parameters (Ag:In:Se ratios) and size parameters (5-50 nm) during synthesis, which quantum effects to produce steep emission spectra, while maintaining ease of manufacture through solution-based methods that naturally control size distribution, balancing manufacturing precision with production simplicity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a light emitter capable of producing strong, high-resolution luminescence in the near-infrared region, suitable for bioimaging, allowing for dynamic analysis of biological images with high sensitivity and multiple colors, effectively addressing the limitations of existing bioimaging techniques.

Implementation Method 1

through light absorption, electrons and holes are recombined to produce luminescence

Methodology Applied
Scientific EffectLight absorption and luminescence emission: Photoluminescence

Implementation Method 2

achieving band-edge luminescence with reduced energy loss

Methodology Applied
Scientific EffectBand-edge luminescence: Luminescence

Implementation Method 3

heating them to improve crystallinity and suppress defect generation

Methodology Applied
Scientific EffectThermal heating: Heating

Implementation Method 4

heating the mixed solution at a reaction temperature higher than the predetermined temperature for a predetermined period of reaction time

Methodology Applied
Scientific EffectCrystallinity improvement: Crystallisation

Data Source

PatentUS11111434B2Light emitter, method for producing light emitter, and biological substance labeling agent
Publication Date: 2021.09.07 MURATA MFG CO LTD
  • US11111434B2 patent drawing
  • US11111434B2 patent drawing
  • US11111434B2 patent drawing

AI summary

A light emitter is formed from nanoparticles including a compound semiconductor containing an Ag component, In component, and Se component. The peak wavelength of the emission intensity falls within the range of 700 to 1400 nm, and the half-value width ΔH for the peak wavelength is 100 nm or less. The light emitted is configured to emit strong light in the near-infrared region, and which is capable of detecting biological information, and is preferred for bioimaging.